scispace - formally typeset
S

Steffen E. Eikenberry

Researcher at Arizona State University

Publications -  37
Citations -  2504

Steffen E. Eikenberry is an academic researcher from Arizona State University. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 13, co-authored 34 publications receiving 1601 citations.

Papers
More filters
Journal ArticleDOI

To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic

TL;DR: A compartmental model for assessing the community-wide impact of mask use by the general, asymptomatic public is developed, suggesting face masks are potentially of high value in curtailing community transmission and the burden of the COVID-19 pandemic.
Journal ArticleDOI

Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.

TL;DR: This study shows that early termination of the strict social-distancing measures could trigger a devastating second wave with burden similar to those projected before the onset of the restrictive measures, and emphasizes the important role social- Distancing plays in curtailing the burden of COVID-19.
Journal ArticleDOI

To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic

TL;DR: In this article, the authors developed a compartmental model for assessing the community-wide impact of mask use by the general, asymptomatic public, a portion of which may be infectious.
Journal ArticleDOI

A tumor cord model for Doxorubicin delivery and dose optimization in solid tumors

TL;DR: Drug infusion time has a significant effect on the spatial profile of cell mortality within tumor cord systems, and extending infusion times and fractionating large doses are two strategies that may preserve or increase anti-tumor activity and reduce cardiotoxicity by decreasing peak plasma concentration.
Journal ArticleDOI

Rich dynamics of a hepatitis B viral infection model with logistic hepatocyte growth.

TL;DR: Modifications are made to the dynamics of a well-studied model of HBV pathogenesis that replaces the constant infusion of healthy hepatocytes with a logistic growth term and the mass action infection term by a standard incidence function.